Ken Griffin's Citadel posted a 1.7% gain in October, a month that turned genuinely painful for the hedge fund industry and left several of its biggest names nursing losses. That result pushed Citadel's 2026 gains to 15.3%, putting it well ahead of the pack among the large multistrategy funds that compete most directly with it.

The funds that fell behind are not small or obscure. Izzy Englander's Millennium Management, one of the largest hedge funds on the planet, lost 2.3% in October and now sits at just 5.7% for the year. Michael Gelband's ExodusPoint Capital dropped 2.4%, leaving it up only 1.6% for 2026. Dymon Asia lost 1.8% on the month. Man Group's 1783 fund shed 1.8% as well.

So what went wrong for everyone except Citadel?

Three things hit at once. Stock pickers ran into a market that opened October at an all-time high and then reversed sharply, with major tech names selling off after that early peak. Credit investors, meanwhile, are still absorbing the pressure of rising interest rates and an unusually heavy supply of new corporate debt, driven in part by the enormous capital needs of cloud and AI infrastructure companies. And macro traders got blindsided when Brazil reelected left-wing president Luiz Inácio Lula da Silva, an outcome that moved currencies and emerging market positions in ways many funds hadn't positioned for.

The collision of all three on a single month produced what Goldman Sachs' prime brokerage desk identified as one of the worst single days for hedge funds since the COVID-19 pandemic. October 22 was the epicenter: tech stocks like Meta fell while oil prices surged, a combination that punished funds positioned for either one independently.

Why this gap matters

Multistrategy funds like Citadel, Millennium, and ExodusPoint are specifically built to avoid exactly this kind of synchronized loss. Their model is diversification across many independent trading teams, with tight controls designed to cut losses before they compound. The pitch to investors is that they can navigate rough markets better than anyone. October tested that promise, and the gap in outcomes was unusually wide.

A 15.3% return versus 1.6% or 5.7% is not a minor difference in a world where these funds charge among the highest fees in finance, often taking 30% or more of any profits on top of a management fee. For the large institutions, university endowments, and pension funds that allocate money to these managers, the October gap raises a pointed question about whether the fees at the lagging firms are still earning their keep.

For ordinary people, the direct exposure is limited but real. Many pension funds and university endowments hold positions in funds like these. A year in which Millennium or ExodusPoint underperforms by ten percentage points or more relative to Citadel compounds over time in ways that can affect retirement fund returns and institutional budgets.

The deeper story is about concentration. When a single firm consistently separates itself from a large peer group, capital tends to follow it. Citadel already manages $77 billion. Persistent outperformance over a bruising year makes it harder for rivals to attract the allocations they need to maintain their own infrastructure and talent. In a business where the best traders tend to move toward whoever is winning, October may have consequences that outlast the month itself.